Randomly amplified polymorphic DNA解析で同一パターンを示すNocardia farcinica 感染の集団発生 ★
2006.04.30
Outbreak of Nocardia farcinica infection with the same pattern in randomly amplified polymorphic DNA analysis
S. Kachi*, M. Okazaki, H. Takeda, H. Igarashi, O. Kobayashi, H. Watanabe, K. Nakata, S. Kawai, M. Aoshima, T. Watanabe, H. Goto
*Kyorin University School of Medicine, Japan
Jouranl of Hospital Infection (2006) 62, 502-506
著者らは、Nocardia farcinicaによるノカルジア症を同一病棟で6カ月間に3例経験した。Randomly amplified polymorphic DNA(RAPD)法による遺伝子解析の結果は、同じパターンを示した。したがって、これらの3例は同一のN. farcinica菌株によるものと考えられ、院内感染の可能性を示唆している。
サマリー 原文(英語)はこちら
監訳者コメント:
起因菌不明の日和見感染に際し、N. farcinicaを念頭に置く必要性を感じさせる論文である。本報告は日本国内からなされており、どの施設でも起こりうる事例である。
同カテゴリの記事
2025.03.03
Can screening and decontamination procedures performed on an outpatient basis reduce colonization with Staphylococcus aureus and mitigate associated complications in patients undergoing elective hospital procedures? A controlled intervention study (STAUfrei) A. Bauer*, H. Sturm, P. Martus, B. Brüggenjürgen, H. Eberhardt, E. Mayer, R. Schulz, J. Bernhold, T. Krause, P. Höllein, J. Liese, S. Wolf, S. Joos, M. Grünewald, on behalf of the STAUfrei Consortium *University Hospital Tübingen, Germany Journal of Hospital Infection (2025) 157, 19-28
2025.08.06
Healthcare workers’ attitudes to lateral flow device testing and sick leave for influenza-like illness in the UK: a hypothetical scenario-based study K. Munro*, Q. Bustamante, L. Findlater, D. Sparkes, G.J. Rubin, A. Atti, S. Foulkes, S. Hopkins, V. Hall, J. Islam *SIREN Study Team, UK Health Security Agency, London, UK Journal of Hospital Infection (2025) 162, 167-173
Consumption of alcohol-based hand rub in French nursing homes: results from a nationwide survey, 2018-2019 O. Ali-Brandmeyer*, K. Blanckaert, M. Nion-Huang, L. Simon, G. Birgand, the CPias Network *Centre d’appui à la prévention des infections associées aux soins Grand Est, France Journal of Hospital Infection (2021) 118, 27-31
2023.01.06
European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018–2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI) V.F. Viprey*, G. Granata, K.E.W. Vendrik, G.L. Davis, N. Petrosillo, E.J. Kuijper, T. Vilken, C. Lammens, J.J. Schotsman, A.D. Benson, M.A. Cataldo, T.I.I. van der Kooi, M.H. Wilcox, K.A. Davies, on behalf of the COMBACTE-CDI consortium *University of Leeds, UK Journal of Hospital Infection (2023) 131, 213-220
2022.10.28
Environmental detection of SARS-CoV-2 in hospital rooms in different wards of a university hospital K. Barrigah-Benissan*, J. Ory, A. Boudet, R. Stephan, A. Sotto, J-P. Lavigne *University of Montpellier, CHU Nîmes, France Journal of Hospital Infection (2022) 128, 74-79
